Phreesia had its Relative Strength (RS) Rating upgraded from 68 to 72 Wednesday — a welcome improvement, but still shy of the 80 or better score you prefer to see.
Can You Really Time The Stock Market?
This proprietary rating tracks market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the last 52 weeks matched up against all other stocks.
History shows that the top-performing stocks typically have an RS Rating of over 80 in the early stages of their moves. See if Phreesia can continue to rebound and hit that benchmark.
Phreesia is working on a consolidation with a 30.53 entry. See if it can clear the breakout price in volume at least 40% above average.
The company posted 0% earnings growth in the latest quarterly report, while sales growth came in at 15%. The company is expected to report its latest results on or around May 28.
The company holds the No. 6 rank among its peers in the Computer Software-Medical industry group. Waystar Holding, OptimizeRx and Privia Health Group are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
